Unless otherwise indicated, all anhydrous solvents were commercially obtained and stored under nitrogen. Reactions were performed under an atmosphere of dry nitrogen in oven dried glassware and were monitored for completeness by thin layer chromatography (TLC) using silica gel 60 F-254 (0.25 mm) plates with detection with UV light.
1 H-NMR spectra were recorded on dilute solutions in CDCl 3 or CD 3 OD at 300 MHz. Chemical shifts are reported in parts per million () downfield from tetramethylsilane (TMS). Coupling constants (J) are reported in Hz. Electrospray ionization mass spectra were acquired on an Bruker Esquire LC00066. Flash chromatography was carried out with silica gel (40-63 micron). Preparative reverse phase HPLC was performed on an automated Varian Prep star system using a gradient of 20% MeOH to 100% MeOH (with 0.1% trifluoroacetic acid) at 12 mL/min over 30 min using a YMC S5 ODS column (20x100 mm, Waters Inc.). All compounds tested on parasites were purified to a single peak by HPLC as described above. HPLC purified compounds were submitted to 1 H-NMR analysis, and compounds were submitted to testing on parasites if the 1 H-NMR spectrum was free of detectable non-compound peaks (estimated purity at least 95%).
2-Amino-1-(3-chlorophenyl)ethanol (5).
Trimethylsilyl cyanide (2.5 mL, 18.5 mmol) was added to a solution of m-chlorobenzaldehyde 4
(1.62 mL, 14.2 mmol) and catalytic ZnI 2 in dry CH 2 Cl 2 (60 mL) under an atmosphere of nitrogen.
The reaction mixture was stirred at room temperature for 3 hours, and washed with water, dried over Na 2 SO 4 . The solution was then concentrated to give a colorless liquid which was used without further purification in the next step. A solution of O-silylchlorophenyl cyanohydrin in THF (30 mL) was added dropwise to a suspension of LiAlH 4 (1.08g, 28.4 mmol) in THF (30 mL), which was cooled with an ice water bath. The reaction mixture was stirred at room S2 temperature for 2 hours, then cooled in an ice bath as water was slowly added. After stirring for 30 min at room temperature, the mixture was filtered, the precipitate was washed with additional THF and again filtered. The combined filtrates were dried over Na 2 SO 4 , filtered and concentrated to give the desired product (1.7 g, 9.95 mmol) 
2-(4-Bromobenzylamino)-1-(3-chlorophenyl)ethanol (6).
To a solution of compound 5 (1.2 g, 6.99 mmol) in methanol (30 mL) was added pbromobenzaldehyde (1.42g, 7.69 mmol) . To this reaction mixture triethylamine (1.06 mL, 7.68 mmol) was added and stirred for 6 hours under a nitrogen atmosphere. The reaction mixture was cooled and NaBH 4 (531 mg, 13.9 mmol) was added. The mixture was stirred overnight. After completion of the reaction methanol was evaporated, the residue was dissolved in CH 2 Cl 2 and washed with water, brine, dried over Na 2 SO 4 and evaporated. The residue was purified by flash chromatography on silica gel to give the title compound 6 (1.78 g, 5.24 mmol) and 5.4 Hz), 2.98 (dd, 1H, J = 12.9 and 6.0 Hz).
6-Bromo-4-(2,6-difluorophenyl)-1,2,3,4-tetrahydroisoquinoline
The compound was prepared by following the procedure described for the synthesis of 6-bromo- (m, 1H).
6-Bromo-4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinoline (7).
To a stirred solution of 6bromo-4-(3-chlorophenyl)-1,2,3,4-tetrahydroisoquinoline (900 mg, 2.79 mmol) in CH 2 Cl 2 was added Et 3 N (0.466 mL, 3.35 mmol) and the solution was stirred in an ice bath. Catalytic DMAP and triphenylmethyl chloride (1.16 g, 4.19 mmol) were added in one portion, and the reaction mixture was stirred vigorously under nitrogen atmosphere at room temperature for 18 hours. The reaction mixture was quenched with water, and extracted with CH 2 Cl 2 , and dried over Na 2 SO 4 . The organic layer was evaporated to yield the crude product which was purified by flash chromatography on silica gel to get the pure product 7 ( 6-Bromo-4-(2,6-difluorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinoline.
The compound was prepared by following the procedure described for the synthesis of 7. 6-Bromo-4-(2,6-difluorophenyl)-1,2,3,4-tetrahydroisoquinoline (1.95 g, 6 mmol) was reacted with trityl chloride (5g, 18 mmol) to produce the product (3.05 g, 5.4 mmol) in 90% yield. 1 (m, 1H), 3.14-3.04 (m, 1H), 2.28-2.12 (m, 1H).
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4-Chloro-N-methoxy-N-methylbenzamide (9).
4-Chlorobenzoic acid 8 (20.0 g, 0.128 mols) was placed in a 500 mL round-bottomed flask.
Thionyl chloride (120 mL) was added, and the mixture was refluxed overnight. 
(4-Chlorophenyl)(1-methyl-1H-imidazol-5-yl)methanone (11).
A flame-dried 125 mL round-bottomed flask was charged with a stir bar, pressurized with dry nitrogen gas and charged with freshly distilled N-methylimidazole 10 (3.0 mL, 37.6 mmol). The flask was sealed with a new rubber septum, and anhydrous THF (30 mL) was added. The solution was stirred for about 10 min, and then the temperature was lowered to -78 °C and stirred for an additional 10 min. Then freshly titrated n-butyl lithium (16.2 mL, 41.3 mmol, 2.5 M in hexane) was added dropwise through the septum over a period of 10 min under an atmosphere of dry nitrogen. A slight color change to pale yellow was observed. This was allowed to stir at this temperature for 45 min, and then 99% chlorotriethylsilane (6.3 mL, 37.6 mmol) was added dropwise over 5 min. The reaction was allowed to stir for 1 h at -78 °C, at which point freshly titrated n-butyl lithium (15.0 mL, 37.6 mmol) was added dropwise through the septum over a period of 10 min and allowed to stir at -78 °C for an additional 45 min. A separate flask was flame-dried and charged with Weinreb amide 9 (5.0 g, 25.1 mmol) and sealed. Then anhydrous THF (15 mL) was added and the mixture was stirred at room temperature for 10 min, and then at the appropriate time, transferred via cannula to the flask containing the in situ generated C-2 triethylsilyl protected N-methylimidazole at a slow rate to maintain low temperature as indicated by the slow sublimation of CO 2 . The mixture was left to stir overnight and became a deep-red color. The reaction was quenched by the addition of 1 M HCl until the pH of the aqueous phase was no longer basic, as indicated by litmus paper, and then allowed to stir for one hour. The pH
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of the aqueous phase was adjusted to above 8 with 1.5 M NaOH, and the mixture was partitioned between CHCl 3 and water. The organic phase was washed with brine and dried with anhydrous The compound was prepared by following the procedure described for the synthesis of 12. 6-Bromo-4-(2,6-difluorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinoline (1.73 g, 3.05 mmol) was treated with BuLi (1.83 mL, 4.58 mmol) followed by addition of compound 11 (640 mg, 2.9 mmol) to afford the product (1.12 g, 1.58 mmol) in 52% yield. (4-Chlorophenyl)(isoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol.
Compound was prepared from 6-bromoisoquinoline as described for the synthesis of compound 12. 6-Bromoisoquinoline (208 mg, 1 mmol) was treated with BuLi (0.5 mL, 1.2 mmol) followed by addition of compound 11 (220 mg, 1 mmol) to afford the product (209.8 mg, 0.6 mmol) in 60% yield. (4-Chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol 12 (300 mg, 0.42 mmol) was dissolved in 20% TFA in CH 2 Cl 2 (20 mL) and stirred under a nitrogen atmosphere at room temperature for overnight. 46-6.60 (m, 11H), 6.28 (s, 1H), 4.60-4.48 (m, 1H), 4.26-4.02 (m, 2H), 3.51-3.38 (m, 1H), 3.32 (s, 3H), 3.28-3.12 (m, 1H) .
(4-Chlorophenyl)(4-(3-chlorophenyl)isoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol (13).
To a solution of (4-Chlorophenyl)(4-(3-chlorophenyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol (167 mg, 0.36 mmol) in dioxane (30 mL) was added MnO 2 (628 mg, 7.22 mmol) and the resulting mixture was stirred under nitrogen atmosphere at reflux temperature for 24 hours. The reaction mixture was filtered through a pad of celite and the filtrate was concentrated under reduced pressure. The crude residue was purified by flash column chromatography on silica gel to afford the pure product 13 (106 mg, 0.23 mmol) in 64% yield. 
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(4-Chlorophenyl)(4-(2,6-difluorophenyl)isoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol.
The compound was prepared by following the procedure described for the synthesis of 13. (4-Chlorophenyl)(4-(2,6-difluorophenyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol- 
4-(3-Chlorophenyl)-6-((4-chlorophenyl)(methoxy)(1-methyl-1H-imidazol-5-yl)methyl)isoquinoline (14).
(4-Chlorophenyl)(4-(3-chlorophenyl)isoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol 13
(30 mg, 0.065 mmol) was dissolved in thionyl chloride (2 mL) and stirred at room temperature under an atmosphere of dry N 2 for 3 hours. SOCl 2 was removed under reduced pressure. The residue was taken up in CH 2 Cl 2 and concentrated under vacuum. The resulting solid was dissolved in MeOH (5 mL) and stirred under nitrogen atmosphere at reflux temperature for overnight. The mixture was cooled to room temperature and evaporated in vacuo. The crude residue was purified by flash column chromatography on silica gel to afford pure product 14 (24.6 mg, 0.052 mmol) in 80% yield. MS m/z 474.1 (M + H + ).
6-((4-Chlorophenyl)(methoxy)(1-methyl-1H-imidazol-5-yl)methyl)-4-(2,6-difluorophenyl)isoquinoline (15).
The compound was prepared by following the procedure described for the synthesis of 14. (4-Chlorophenyl)(4-(2,6-difluorophenyl)isoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol (37 mg, 0.08 mmol) was treated with neat SOCl 2 (2 mL) and followed by MeOH (5 mL) at reflux temperature to afford the product (32mg, 0.07 mmol) in 84% yield. 1 
6-((4-Chlorophenyl)(methoxy)(1-methyl-1H-imidazol-5-yl)methyl)isoquinoline (16).
